[1] SUI Z,ZHANG L,HUO Y,et al.Bioactive components of velvet antlers and their pharmacological properties[J].Journal of Pharmaceutical and Biomedical Analysis,2014,87:229-240. [2] 李勋胜,赵海平,李春义,等.鹿茸神经再生的研究进展[J].生命科学,2021,33(8):955-961. LI X S,ZHAO H P,LI C Y,et al.Research progress of deer antler nerve regeneration[J].Chinese Bulletin of Life Sciences,2021,33(8):955-961.(in Chinese) [3] JOHNSON D E,LEE P L,LU J,et al.Diverse forms of a receptor foracidic and basic fibroblast growth factors[J].Molecular and Cellular Biology,1990,10:4728-4736. [4] OLSEN S K,IBRAHIMI O A,RAUCCI A,et al.Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity[J].Proceedings of the National Academy of Sciences of the United States of America,2004,101(4):935-940. [5] ESWARAKUMAR V P,LAX I,SCHLESSINGER J.Cellular signaling by fibroblast growth factor receptors[J].Cytokine and Growth Factor Reviews,2005,16(2):139-149. [6] 徐伟.FGFR2在颅骨缺损修复和骨形成中的作用研究[D].重庆:第三军医大学,2014. XU W.Role of FGFR2 in calvarial defect healing and bone formation[D].Chongqing:Third Military Medical University,2014.(in Chinese) [7] WANG Y,SUN M,UHLHORN V L,et al.Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2+P253R mice[J].BioMed Central Developmental Biology,2010,10:22. [8] BEENKEN A,MOHAMMADI M.The FGF family:Biology,pathophysiology and therapy[J].Nature Reviews Drug Discovery,2009,8(3):235-253. [9] LAI A K,HOU W L,VERDON D J,et al.The distribution of the growth factors FGF-2 and VEGF,and their receptors,in growing red deer antler[J].Tissue and Cell,2007,39(1):35-46. [10] 吴晋强,曹校瑞,闫瑞琴,等.FGF21及其受体FGFR1和FGFR2在小鼠毛囊第1生长周期的表达[J].畜牧兽医学报,2019,50(3):534-543. WU J Q,CAO X R,YAN R Q,et al.Expression of FGF21 and receptors FGFR1,FGFR2 in the first hair follicle growth cycle of mice[J].Acta Veterinaria et Zootechnica Sinica,2019,50(3):534-543.(in Chinese) [11] RICHARDSON G D,BAZZI H,FANTAUZZO K A,et al.KGF and EGF signalling block hair follicle induction and promote interfollicular epidermal fate in developing mouse skin[J].Development,2009,136(13):2153-2164. [12] HU P,DENG Y,BA H,et al.Association analysis of thirty-one single nucleotide polymorphisms with antler weight in sika deer[J].Animal Genetics,2020,51(6):990-991. [13] ZHANG R R,LI Y,XING X M.Comparative antler proteome of sika deer from different developmental stages[J].Scientific Reports,2021,11(1):10484. [14] 胡鹏飞,徐佳萍,艾成,等.利用全基因组重测序分析鹿茸重量相关基因[J].遗传,2017,39(11):1090-1101. HU P F,XU J P,AI C,et al.Screening weight related genes of velvet antlers by whole genome re-sequencing[J]. Hereditas (Beijing),2017,39(11):1090-1101.(in Chinese) [15] JIA B,WANG G W,ZHENG J J,et al.Development of novel EST microsatellite markers for genetic diversity analysis and correlation analysis of velvet antler growth characteristics in sika deer[J]. Hereditas,2020,157(1):24. [16] 杜智恒,白秀娟.梅花鹿生长激素基因单核苷酸多态与产茸量性状的相关性[J].遗传,2007,29(3):337-342. DU Z H,BAI X J.Association analysis between SNPs of the growth hormone gene and antler production in spotted deer[J]. Hereditas (Beijing),2007,29(3):337-342.(in Chinese) [17] YANG F F,HUO L J,YANG L G,et al.Association between melatonin receptor 1A (MTNR1A) gene single-nucleotide polymorphisms and the velvet antler yield of sika deer[J].Molecular Biology Reports,2014,41(4):1901-1906. [18] 徐伟.FGFR2在骨骼发育与骨形成中的作用与机制研究[D].重庆:第三军医大学,2017. XU W.The roles and mechanisms of FGFR2 in skeletal development and bone formation[D].Chongqing:Third Military Medical University,2017.(in Chinese) [19] KATOH M,NAKAGAMA H.FGF receptors:Cancer biology and therapeutics[J].Medicinal Research Reviews,2014,34(2):280-300. [20] FORMISANO L,LU Y,SERVETTO A,et al.Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+breast cancer[J].Nature Communications,2019,10(1):1373. [21] SU X,ZHAN P,GAVINE P R,et al.FGFR2 amplification has prognostic significance in gastric cancer:Results from a large international multicentre study[J].British Journal of Cancer,2014,110(4):967-975. [22] MAEHARA O,SUDA G,NATSUIZAKA M,et al.FGFR2 maintains cancer cell differentiation via AKT signaling in esophageal squamous cell carcinoma[J].Cancer Biology and Therapy,2021,22(5-6):372-380. [23] CLEARY J M,RAGHAVAN S,WU Q,et al.FGFR2 extracellular domain in-frame deletions are therapeutically targetable genomic alterations that function as oncogenic drivers in cholangiocarcinoma[J].Cancer Discovery,2021,11(10):2488-2505. |